US Stock MarketDetailed Quotes

ITRM Iterum Therapeutics

Watchlist
  • 1.5400
  • +0.0400+2.67%
Close Feb 14 16:00 ET
  • 1.5900
  • +0.0500+3.25%
Post 19:51 ET
53.26MMarket Cap-1.22P/E (TTM)

Iterum Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
31.93%-26.77M
66.86%-4.26M
71.16%-2.67M
11.44%-6.76M
-36.42%-13.08M
-112.91%-39.33M
-201.13%-12.84M
-104.12%-9.27M
-21.84%-7.63M
-181.64%-9.59M
Net income from continuing operations
35.44%-24.77M
46.76%-6.58M
-57.18%-6.09M
59.18%-5M
28.19%-7.1M
13.64%-38.37M
-142.87%-12.36M
86.68%-3.88M
-81.78%-12.24M
-182.54%-9.89M
Operating gains losses
129.57%3.27M
569.84%2.04M
103.28%433K
-57.60%407K
-56.04%386K
-102.57%-11.06M
110.30%305K
-373.05%-13.2M
144.55%960K
116.96%878K
Depreciation and amortization
-83.77%284K
-40.68%261K
-98.17%8K
-98.17%8K
-98.39%7K
-2.78%1.75M
0.23%440K
-2.68%436K
-3.74%438K
-4.80%436K
Other non cash items
20.62%7.17M
-17.83%1.71M
130.05%2.99M
-1.98%1.24M
-5.11%1.25M
10.44%5.95M
188.60%2.08M
-2.11%1.3M
-14.17%1.26M
-29.84%1.31M
Change In working capital
-560.77%-12.73M
38.13%-1.42M
-101.23%-73K
-288.82%-3.48M
-185.22%-7.76M
19.56%2.76M
-197.54%-2.3M
3,023.68%5.94M
243.87%1.84M
-359.29%-2.72M
-Change in prepaid assets
16.47%-2.66M
85.99%-88K
-900.00%-1.35M
-12.85%-1.45M
115.64%226K
-105.54%-3.19M
-428.80%-628K
144.95%169K
17.00%-1.28M
-898.34%-1.45M
-Change in payables and accrued expense
-272.53%-9.86M
21.20%-1.42M
-78.40%1.25M
-157.32%-1.74M
-516.39%-7.93M
12.44%5.71M
-183.97%-1.81M
371.38%5.77M
178.99%3.04M
-309.27%-1.29M
-Change in other current assets
-94.72%17K
----
----
----
----
--322K
----
----
----
----
-Change in other current liabilities
-8.76%-385K
14.29%-84K
-96.15%-102K
2.94%-99K
1.96%-100K
50.00%-354K
2.00%-98K
68.48%-52K
62.08%-102K
41.38%-102K
-Change in other working capital
-42.80%155K
----
----
-200.53%-189K
-57.02%49K
153.14%271K
----
----
133.87%188K
-73.30%114K
Cash from discontinued investing activities
Operating cash flow
31.93%-26.77M
66.86%-4.26M
71.16%-2.67M
11.44%-6.76M
-36.42%-13.08M
-112.91%-39.33M
-201.13%-12.84M
-104.12%-9.27M
-21.84%-7.63M
-181.64%-9.59M
Investing cash flow
Cash flow from continuing investing activities
-21.97%18.21M
-91.87%1.1M
1,483.33%5.7M
-3.45%4.2M
41.23%7.21M
67.20%23.34M
208.89%13.52M
-97.73%360K
127.41%4.35M
-46.77%5.11M
Net PPE purchase and sale
84.62%-2K
--0
--0
----
----
79.03%-13K
--0
142.86%3K
----
----
Net investment purchase and sale
-22.01%18.21M
-91.87%1.1M
1,496.64%5.7M
-3.76%4.2M
41.23%7.21M
66.55%23.35M
205.74%13.52M
-97.75%357K
127.53%4.36M
-46.77%5.11M
Cash from discontinued investing activities
Investing cash flow
-21.97%18.21M
-91.87%1.1M
1,483.33%5.7M
-3.45%4.2M
41.23%7.21M
67.20%23.34M
208.89%13.52M
-97.73%360K
127.41%4.35M
-46.77%5.11M
Financing cash flow
Cash flow from continuing financing activities
2,481.33%26.69M
2,256.03%13.88M
54,200.00%5.43M
-16.50%167K
2,971.06%7.22M
156.88%1.03M
36.03%589K
10K
200K
110.44%235K
Net issuance payments of debt
--0
----
----
----
----
--0
----
----
----
----
Net common stock issuance
2,481.33%26.69M
2,256.03%13.88M
54,200.00%5.43M
-16.50%167K
2,971.06%7.22M
138.80%1.03M
36.03%589K
--10K
--200K
--235K
Cash from discontinued financing activities
Financing cash flow
2,481.33%26.69M
2,256.03%13.88M
54,200.00%5.43M
-16.50%167K
2,971.06%7.22M
156.88%1.03M
36.03%589K
--10K
--200K
110.44%235K
Net cash flow
Beginning cash position
-71.10%6.11M
177.11%13.44M
-63.61%5.01M
-55.99%7.42M
-71.10%6.11M
-23.21%21.13M
-76.40%4.85M
48.47%13.77M
-46.33%16.87M
-23.21%21.13M
Current changes in cash
221.18%18.13M
744.84%10.72M
195.09%8.46M
22.37%-2.4M
131.65%1.35M
-136.19%-14.96M
132.42%1.27M
-178.66%-8.9M
86.06%-3.09M
-207.92%-4.25M
Effect of exchange rate changes
-22.95%-75K
85.71%-2K
-21.74%-28K
-50.00%-18K
-125.00%-27K
-22.00%-61K
-151.85%-14K
17.86%-23K
55.56%-12K
45.45%-12K
End cash Position
295.72%24.16M
295.72%24.16M
177.11%13.44M
-63.61%5.01M
-55.99%7.42M
-71.10%6.11M
-71.10%6.11M
-76.40%4.85M
48.47%13.77M
-46.33%16.87M
Free cash flow
31.95%-26.77M
66.86%-4.26M
71.15%-2.67M
11.60%-6.76M
-36.42%-13.08M
-112.26%-39.34M
-197.98%-12.84M
-103.74%-9.26M
-21.90%-7.65M
-181.64%-9.59M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 31.93%-26.77M66.86%-4.26M71.16%-2.67M11.44%-6.76M-36.42%-13.08M-112.91%-39.33M-201.13%-12.84M-104.12%-9.27M-21.84%-7.63M-181.64%-9.59M
Net income from continuing operations 35.44%-24.77M46.76%-6.58M-57.18%-6.09M59.18%-5M28.19%-7.1M13.64%-38.37M-142.87%-12.36M86.68%-3.88M-81.78%-12.24M-182.54%-9.89M
Operating gains losses 129.57%3.27M569.84%2.04M103.28%433K-57.60%407K-56.04%386K-102.57%-11.06M110.30%305K-373.05%-13.2M144.55%960K116.96%878K
Depreciation and amortization -83.77%284K-40.68%261K-98.17%8K-98.17%8K-98.39%7K-2.78%1.75M0.23%440K-2.68%436K-3.74%438K-4.80%436K
Other non cash items 20.62%7.17M-17.83%1.71M130.05%2.99M-1.98%1.24M-5.11%1.25M10.44%5.95M188.60%2.08M-2.11%1.3M-14.17%1.26M-29.84%1.31M
Change In working capital -560.77%-12.73M38.13%-1.42M-101.23%-73K-288.82%-3.48M-185.22%-7.76M19.56%2.76M-197.54%-2.3M3,023.68%5.94M243.87%1.84M-359.29%-2.72M
-Change in prepaid assets 16.47%-2.66M85.99%-88K-900.00%-1.35M-12.85%-1.45M115.64%226K-105.54%-3.19M-428.80%-628K144.95%169K17.00%-1.28M-898.34%-1.45M
-Change in payables and accrued expense -272.53%-9.86M21.20%-1.42M-78.40%1.25M-157.32%-1.74M-516.39%-7.93M12.44%5.71M-183.97%-1.81M371.38%5.77M178.99%3.04M-309.27%-1.29M
-Change in other current assets -94.72%17K------------------322K----------------
-Change in other current liabilities -8.76%-385K14.29%-84K-96.15%-102K2.94%-99K1.96%-100K50.00%-354K2.00%-98K68.48%-52K62.08%-102K41.38%-102K
-Change in other working capital -42.80%155K---------200.53%-189K-57.02%49K153.14%271K--------133.87%188K-73.30%114K
Cash from discontinued investing activities
Operating cash flow 31.93%-26.77M66.86%-4.26M71.16%-2.67M11.44%-6.76M-36.42%-13.08M-112.91%-39.33M-201.13%-12.84M-104.12%-9.27M-21.84%-7.63M-181.64%-9.59M
Investing cash flow
Cash flow from continuing investing activities -21.97%18.21M-91.87%1.1M1,483.33%5.7M-3.45%4.2M41.23%7.21M67.20%23.34M208.89%13.52M-97.73%360K127.41%4.35M-46.77%5.11M
Net PPE purchase and sale 84.62%-2K--0--0--------79.03%-13K--0142.86%3K--------
Net investment purchase and sale -22.01%18.21M-91.87%1.1M1,496.64%5.7M-3.76%4.2M41.23%7.21M66.55%23.35M205.74%13.52M-97.75%357K127.53%4.36M-46.77%5.11M
Cash from discontinued investing activities
Investing cash flow -21.97%18.21M-91.87%1.1M1,483.33%5.7M-3.45%4.2M41.23%7.21M67.20%23.34M208.89%13.52M-97.73%360K127.41%4.35M-46.77%5.11M
Financing cash flow
Cash flow from continuing financing activities 2,481.33%26.69M2,256.03%13.88M54,200.00%5.43M-16.50%167K2,971.06%7.22M156.88%1.03M36.03%589K10K200K110.44%235K
Net issuance payments of debt --0------------------0----------------
Net common stock issuance 2,481.33%26.69M2,256.03%13.88M54,200.00%5.43M-16.50%167K2,971.06%7.22M138.80%1.03M36.03%589K--10K--200K--235K
Cash from discontinued financing activities
Financing cash flow 2,481.33%26.69M2,256.03%13.88M54,200.00%5.43M-16.50%167K2,971.06%7.22M156.88%1.03M36.03%589K--10K--200K110.44%235K
Net cash flow
Beginning cash position -71.10%6.11M177.11%13.44M-63.61%5.01M-55.99%7.42M-71.10%6.11M-23.21%21.13M-76.40%4.85M48.47%13.77M-46.33%16.87M-23.21%21.13M
Current changes in cash 221.18%18.13M744.84%10.72M195.09%8.46M22.37%-2.4M131.65%1.35M-136.19%-14.96M132.42%1.27M-178.66%-8.9M86.06%-3.09M-207.92%-4.25M
Effect of exchange rate changes -22.95%-75K85.71%-2K-21.74%-28K-50.00%-18K-125.00%-27K-22.00%-61K-151.85%-14K17.86%-23K55.56%-12K45.45%-12K
End cash Position 295.72%24.16M295.72%24.16M177.11%13.44M-63.61%5.01M-55.99%7.42M-71.10%6.11M-71.10%6.11M-76.40%4.85M48.47%13.77M-46.33%16.87M
Free cash flow 31.95%-26.77M66.86%-4.26M71.15%-2.67M11.60%-6.76M-36.42%-13.08M-112.26%-39.34M-197.98%-12.84M-103.74%-9.26M-21.90%-7.65M-181.64%-9.59M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--------
Trending Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
Petroleo Brasileiro SA Petrobras
PBR
+4.45%
Strategy
MSTR
+3.94%
NVIDIA
NVDA
+2.63%
Vale SA
VALE
+1.99%
KB Home
KBH
+1.28%

Unlock the Full List